The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer

被引:7
作者
Santana-Davila, Rafael [1 ]
Chow, Laura Q. M. [1 ]
机构
[1] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA 98195 USA
关键词
chemo-immunotherapy; first-line; immune checkpoint inhibitors; immunotherapy; lung cancer; NSCLC; treatment naive; PACLITAXEL PLUS CARBOPLATIN; OPEN-LABEL; PHASE-III; PEMBROLIZUMAB; NIVOLUMAB; DOCETAXEL; CHEMOTHERAPY; MULTICENTER; IPILIMUMAB;
D O I
10.2217/fon-2017-0124
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:191 / 194
页数:4
相关论文
共 50 条
[31]   The safety of second-line treatment options for non-small cell lung cancer [J].
Rossi, Antonio ;
Maione, Paolo ;
Santabarbara, Giuseppe ;
Sacco, Paola Claudia ;
Casaluce, Francesca ;
Sgambato, Assunta ;
Barzelloni, Maria Luisa ;
Palazzolo, Giovanni ;
Gridelli, Cesare .
EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) :471-479
[32]   Clinical consideration for choosing combination therapies in advanced non-small-cell lung cancer: age, Eastern Cooperative Organization performance status 2, steroids and antibiotics [J].
De Giglio, Andrea ;
Nuvola, Giacomo ;
Baldini, Capucine .
FUTURE ONCOLOGY, 2020, 16 (23) :1683-1690
[33]   Immune checkpoint inhibitors in first-line therapy of advanced non-small cell lung cancer [J].
Remon, Jordi ;
Besse, Benjamin .
CURRENT OPINION IN ONCOLOGY, 2017, 29 (02) :97-104
[34]   A Review of Immunotherapy in Non-Small-Cell Lung Cancer [J].
Capella, Mariana Pilon ;
Pang, Steph A. ;
Magalhaes, Marcos A. ;
Esfahani, Khashayar .
CURRENT ONCOLOGY, 2024, 31 (06) :3495-3512
[35]   Vaccination therapy for non-small-cell lung cancer [J].
Cuppens, Kristof ;
Vansteenkiste, Johan .
CURRENT OPINION IN ONCOLOGY, 2014, 26 (02) :165-170
[36]   Carboplatin-containing regimens as front-line treatment for advanced non-small-cell lung cancer in two groups of elderly [J].
Giuliani, Jacopo ;
Piacentini, Paolo ;
Greco, Filippo ;
Mercanti, Anna ;
Trolese, Anna Rita ;
Furini, Lara ;
Durante, Emilia ;
Moratello, Giacomo ;
Tognetto, Michele ;
Bonetti, Andrea .
JOURNAL OF CHEMOTHERAPY, 2014, 26 (02) :111-116
[37]   Immune checkpoint therapy for non-small-cell lung cancer: an update [J].
Xia, Bing ;
Herbst, Roy S. .
IMMUNOTHERAPY, 2016, 8 (03) :279-298
[38]   Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer [J].
Sa, Huanlan ;
Song, Peng ;
Ma, Kewei ;
Gao, Yong ;
Zhang, Li ;
Wang, Deqiang .
ONCOTARGETS AND THERAPY, 2019, 12 :8151-8159
[39]   Oxaliplatin in First-line Therapy for Advanced Non-Small-Cell Lung Cancer [J].
Raez, Luis E. ;
Kobina, Svetlana ;
Santos, Edgardo S. .
CLINICAL LUNG CANCER, 2010, 11 (01) :18-24
[40]   Neoadjuvant immune checkpoint inhibitors in resectable non-small-cell lung cancer: a systematic review [J].
Ulas, E. B. ;
Dickhoff, C. ;
Schneiders, F. L. ;
Senan, S. ;
Bahce, I. .
ESMO OPEN, 2021, 6 (05)